Global Oral Drug Delivery Market Size, Share, Growth Analysis Report - Forecast 2034

Oral Drug Delivery Market Size

The Global Oral Drug Delivery Market Size was USD 105.23 Billion in 2024 and is expected to reach USD 220.96 Billion by 2034, growing at a CAGR of 7.7% between 2025 and 2034. Oral drug delivery is the most conducive and favored route of drug administration due to factors such as least sterility constraints, patient compliance, flexibility in the design of the dosage form, ease of production, and cost effectiveness. The oral route of drug administration has developed over the last few years with the help of technologies and clinical trials.

Request Free Sample

The market is primarily driven by the increase in the prevalence of chronic diseases, which has led to an increase in the demand for oral drug delivery systems for the treatment of such diseases. To maintain the efficiency of oral drug delivery, there has been increased utilization of nanocarriers for oral drug delivery. Recent developments such as dome tablets, intestinal patches, polymer nanosystems, and dual drug tablets have been revolutionizing the field.

Growth Factors

The rising prevalence of chronic diseases has been driving the oral drug delivery market. The growth in research and development by various pharmaceutical companies has boosted the market. Among the drug delivery routes, oral drug delivery is the most preferred one in various therapeutic areas, which is also the reason to boost this market.

The growth in the biologics market and the increasing penetration of health insurance will boost market growth. Also, an increasing number of pharmaceutical companies have been driving the market. The technological developments and the new product launches in the market have also accelerated the overall drug delivery market.

Key Insights

• As per the analysis shared by our research analyst, the global oral drug delivery market is estimated to grow annually at a CAGR of around 7.7% over the forecast period (2025-2034).
• Regarding revenue, the global oral drug delivery market size was valued at around USD 105.23 Billion in 2024 and is projected to reach USD 220.96 Billion by 2034.
• The oral drug delivery market is projected to grow at a significant rate due to patient preference for non-invasive drug administration, advancements in controlled-release technologies, and rising prevalence of chronic diseases.
• Based on Formulation Type, the Tablets segment is expected to lead the global market.
• On the basis of Drug Release Type, the Immediate Release segment is growing at a high rate and will continue to dominate the global market.
• Based on the Therapeutic Application, the Cardiovascular segment is projected to swipe the largest market share.
• By Distribution Channel, the Hospital Pharmacies segment is expected to dominate the global market.
• Based on region, North America is predicted to dominate the global market during the forecast period.

Request Free Sample

Oral Drug Delivery Market: Segmentation Analysis

The global oral drug delivery market is segmented based on Formulation Type, Drug Release Type, Therapeutic Application, Distribution Channel, and region.

Based on Formulation Type, the global oral drug delivery market is divided into Tablets, Capsules, Powders, Syrups, Gels, Others.

On the basis of Drug Release Type, the global oral drug delivery market is bifurcated into Immediate Release, Sustained Release, Controlled Release, Delayed Release.

By Therapeutic Application, the global oral drug delivery market is split into Cardiovascular, Oncology, Infectious Diseases, Diabetes, Gastrointestinal, Others.

In terms of Distribution Channel, the global oral drug delivery market is categorized into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.

Oral Drug Delivery Market Share

Request Free SampleProduct Analysis

This is due to factors such as new production techniques introduced to produce the syrups, their availability in a variety of compositions for the consumers, and their increased effectiveness in treating infections and diseases. The content of the syrups provides useful vitamins, rich minerals, and proteins required for the overall development of the patients. Thus, the health benefits and the wide availability are driving this segment in the oral drug delivery market.

Oral Drug Delivery Market: Report Scope

Regional Analysis

North America held a share of 39% in 2020. This is due to factors such as the presence of a large number of pharmaceutical companies, a robust pharmaceutical industry, drug delivery technology providers, and the rising number of collaborations between technology providers and pharmaceutical companies. Also, the increased demand for self-administration and home healthcare devices, transdermal patches and transmucosal systems for chronic diseases, and increasing applications of inhalers have boosted the market in this region.

Request Free SampleAsia-Pacific is expected to have a CAGR of 9.3% from 2021 to 2028. This is due to factors such as western market saturation and the economic downturn in the United States and Europe. In addition, factors such as the rise in disposable incomes, the increasing penetration of health insurance, the development of healthcare infrastructure, and the increase in chronic diseases are boosting the overall market in this region.

Oral Drug Delivery Market: Competitive Analysis

The report provides a company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market, including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the oral drug delivery market on a global and regional basis.

The global oral drug delivery market is dominated by players like:

• AdhexPharma
• Protalix
• CURE Pharamceutical
• Evonik
• Arx LLC
• Catalent Inc.
• INTELGENX CORP
• Assembly Biosciences Inc.
• Aquestive Therapeutics
• Emisphere Technologies
• ZIM Laboratories Limited
• Adare Pharmaceuticals
• Merrion Pharmaceuticals Plc
• Oramed Pharmaceuticals
• Samyang Corporation
• Chimerix Inc.
• Skypepharma
• Amcor Limited and Unigene Laboratories Inc. among others.

The global oral drug delivery market is segmented as follows;

By Formulation Type

• Tablets
• Capsules
• Powders
• Syrups
• Gels
• Others

By Drug Release Type

• Immediate Release
• Sustained Release
• Controlled Release
• Delayed Release

By Therapeutic Application

• Cardiovascular
• Oncology
• Infectious Diseases
• Diabetes
• Gastrointestinal
• Others

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America